Valganciclovir (Qualitest Pharmaceuticals)
Welcome to the PulseAid listing for the Valganciclovir drug offered from Qualitest Pharmaceuticals. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Qualitest Pharmaceuticals |
NON-PROPRIETARY NAME: | Valganciclovir hydrochloride |
SUBSTANCE NAME: | VALGANCICLOVIR HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-11-04 |
END MARKETING DATE: | 0000-00-00 |
Valganciclovir HUMAN PRESCRIPTION DRUG Details:
Item Description | Valganciclovir from Qualitest Pharmaceuticals |
LABELER NAME: | Qualitest Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 450(mg/1) |
START MARKETING DATE: | 2014-11-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0603-6330_31edb5ce-5732-4f44-af59-7940cac2f0cd |
PRODUCT NDC: | 0603-6330 |
APPLICATION NUMBER: | ANDA200790 |
Other VALGANCICLOVIR HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: